Brief: Passage Bio Inc On July 31, Entered Series Of Sublicense Agreements With Gemma

Passage Bio

01/08/2024 12:37

Aug 1 (Reuters) - Passage Bio Inc  PASG.O :
    * PASSAGE BIO INC: ON JULY 31, ENTERED SERIES OF SUBLICENSE
AGREEMENTS WITH GEMMA
    * PASSAGE BIO: POST GEMMA SUBLICENSES, TO GET INITIAL
PAYMENTS OF
$10 MILLION FOR PURCHASE OF CLINICAL PRODUCT SUPPLY
    * PASSAGE BIO: POST GEMMA SUBLICENSES, TO GET UP TO
ADDITIONAL $10
MILLION CONTINGENT ON COMPLETION BY GEMMA OF CERTAIN BUSINESS
MILESTONES
    * PASSAGE BIO: POST GEMMA SUBLICENSES, TO GET UP TO
ADDITIONAL
$114 MILLION IN DEVELOPMENT AND COMMERCIAL MILESTONE PAYMENTS

Source text for Eikon:  ID:n0001104659-24-084615 
Further company coverage:  PASG.O 

 ((Reuters.Briefs@thomsonreuters.com;))